1cBio, BioMarin Pharmaceutical, Alesta Therapeutics, ALE1, Hypophosphatasia, HPP, Rare Diseases, Biotechnology, Drug Development, Mergers and Acquisitions, Licensing Agreement

San Francisco, California, United States, October 14, 2026 1cBio, Inc., a biopharmaceutical company focused on developing innovative treatments for...